Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 14501830)

1.
3.

Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.

Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N.

Ann Intern Med. 2001 Oct 16;135(8 Pt 1):577-88.

PMID:
11601929
4.

Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.

Julié C, Trésallet C, Brouquet A, Vallot C, Zimmermann U, Mitry E, Radvanyi F, Rouleau E, Lidereau R, Coulet F, Olschwang S, Frébourg T, Rougier P, Nordlinger B, Laurent-Puig P, Penna C, Boileau C, Franc B, Muti C, Hofmann-Radvanyi H.

Am J Gastroenterol. 2008 Nov;103(11):2825-35; quiz 2836. doi: 10.1111/j.1572-0241.2008.02084.x. Epub 2008 Aug 27.

PMID:
18759827
5.

Cost effectiveness of a new strategy to identify HNPCC patients.

Kievit W, de Bruin JH, Adang EM, Severens JL, Kleibeuker JH, Sijmons RH, Ruers TJ, Nagengast FM, Vasen HF, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N.

Gut. 2005 Jan;54(1):97-102.

6.

Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.

Terdiman JP, Gum JR Jr, Conrad PG, Miller GA, Weinberg V, Crawley SC, Levin TR, Reeves C, Schmitt A, Hepburn M, Sleisenger MH, Kim YS.

Gastroenterology. 2001 Jan;120(1):21-30.

PMID:
11208710
7.

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA.

Ann Intern Med. 2011 Jul 19;155(2):69-79. doi: 10.7326/0003-4819-155-2-201107190-00002.

8.

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.

Mvundura M, Grosse SD, Hampel H, Palomaki GE.

Genet Med. 2010 Feb;12(2):93-104. doi: 10.1097/GIM.0b013e3181cd666c.

PMID:
20084010
9.

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

10.

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A.

N Engl J Med. 2005 May 5;352(18):1851-60.

11.

Microsatellite instability analysis in hereditary non-polyposis colon cancer using the Bethesda consensus panel of microsatellite markers in the absence of proband normal tissue.

Chialina SG, Fornes C, Landi C, de la Vega Elena CD, Nicolorich MV, Dourisboure RJ, Solano A, Solis EA.

BMC Med Genet. 2006 Jan 20;7:5.

12.

Correlations between phenotype and microsatellite instability in HNPCC: implications for genetic testing.

Palmirotta R, Matera S, Curia MC, Aceto G, el Zhobi B, Verginelli F, Guadagni F, Casale V, Stigliano V, Messerini L, Mariani-Costantini R, Battista P, Cama A.

Fam Cancer. 2004;3(2):117-21.

PMID:
15340262
13.

Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer.

Engel C, Forberg J, Holinski-Feder E, Pagenstecher C, Plaschke J, Kloor M, Poremba C, Pox CP, Rüschoff J, Keller G, Dietmaier W, Rümmele P, Friedrichs N, Mangold E, Buettner R, Schackert HK, Kienle P, Stemmler S, Moeslein G, Loeffler M; German HNPCC Consortium.

Int J Cancer. 2006 Jan 1;118(1):115-22.

PMID:
16003745
14.

Genetic testing for hereditary nonpolyposis colorectal cancer.

Hoedema R, Monroe T, Bos C, Palmer S, Kim D, Marvin M, Luchtefeld M.

Am Surg. 2003 May;69(5):387-91; discussion 391-2.

PMID:
12769209
15.

BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.

Domingo E, Laiho P, Ollikainen M, Pinto M, Wang L, French AJ, Westra J, Frebourg T, Espín E, Armengol M, Hamelin R, Yamamoto H, Hofstra RM, Seruca R, Lindblom A, Peltomäki P, Thibodeau SN, Aaltonen LA, Schwartz S Jr.

J Med Genet. 2004 Sep;41(9):664-8.

16.

Molecular screening for the Lynch syndrome--better than family history?

Lynch HT, Lynch PM.

N Engl J Med. 2005 May 5;352(18):1920-2. No abstract available.

PMID:
15872208
17.

Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.

Vasen HF, Hendriks Y, de Jong AE, van Puijenbroek M, Tops C, Bröcker-Vriends AH, Wijnen JT, Morreau H.

Dis Markers. 2004;20(4-5):207-13. Review.

18.

Microsatellite instability-a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer.

Lamberti C, Kruse R, Ruelfs C, Caspari R, Wang Y, Jungck M, Mathiak M, Malayeri HR, Friedl W, Sauerbruch T, Propping P.

Gut. 1999 Jun;44(6):839-43.

19.

Early-age-at-onset colorectal cancer and microsatellite instability as markers of hereditary nonpolyposis colorectal cancer.

Pucciarelli S, Agostini M, Viel A, Bertorelle R, Russo V, Toppan P, Lise M.

Dis Colon Rectum. 2003 Mar;46(3):305-12.

PMID:
12626904
20.

[The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].

Czakó L, Tiszlavicz L, Takács R, Baradnay G, Lonovics J, Cserni G, Závodná K, Bartosova Z.

Orv Hetil. 2005 May 15;146(20):1009-16. Hungarian.

PMID:
15945244
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk